ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir
NCT02102048
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Atazanavir
Sponsor
University of Roma La Sapienza